2023 年第四季度，Elanco Animal Health 报告称，由于价格上涨和对农场动物产品的需求增加，收入增长了 5%，达到 10.35 亿美元。 In Q4 2023, Elanco Animal Health reported a 5% revenue increase to $1.035 billion, driven by higher prices and demand for farm-animal products.
Elanco Animal Health 报告称，由于农场动物产品价格上涨和需求增加，2023 年第四季度收入增长 5%，达到 10.35 亿美元。 Elanco Animal Health reported a 5% increase in Q4 2023 revenue to $1.035 billion, driven by increased prices and demand for farm-animal products. 尽管第四季度净亏损 1.41 亿美元，而去年同期为 5500 万美元，但该公司全年收入达到 44.17 亿美元。 Despite a $141 million net loss in Q4, compared to $55 million a year prior, the company's full-year revenue reached $4.417 billion. Elanco 的目标是第一季度调整后每股收益为 25-28 美分，收入为 1.16-11.9 亿美元。 Elanco aims to achieve adjusted earnings of 25-28 cents per share and revenue of $1.16-1.19 billion for Q1. 该公司 2024 年指导预计收入在 4.45-45.4 亿美元之间，预计净亏损为 17-6200 万美元。 The company's 2024 guidance projects revenue between $4.45-4.54 billion and an anticipated net loss of $17-62 million.